Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 36, Issue 3, 2003, Pages 187-191

  Yang, Yun Liang ^a   Cheng, Hsiao Hsu ^b   Ho, Yong An ^b   Hsiao, Chin Fu ^b   Lo, Hsiu Jung ^b  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Candida; Fluconazole; Resistance

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDIASIS; DILUTION; FUNGUS ISOLATION; HOSPITAL; NONHUMAN; PREVALENCE; TAIWAN;

ACADEMIC MEDICAL CENTERS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; TAIWAN;

EID: 0142106836     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997;18:369-75.
2. Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 1996;95:19-28.
3. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998;30:121-9.
4. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993;167:1247-51.
5. Yang YL, Lo HJ. Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect 2001;34:79-86.
6. Nguyen MH, Peacock JE Jr., Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23.
7. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002;50:243-60.
8. Patel R, Portela D, Badley AD, Harmsen WS, Larson-Keller JJ, Ilstmp DM, Keating MR, Wiesner RH, Krom RA, Paya CV. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 1996;62:926-34.
9. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MG, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994;34:659-68.
10. Orozco AS, Higginbotham LM, Hitchcock CA, Parkinson T, Falconer D, Ibrahim AS, Ghannoum MA, Filler SG. Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chemother 1998;42:2645-9.
11. Piemonte P, Conte G, Flores C, Barahona O, Araos D, Alfaro J, Fardella P, Thompson L. Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients. Rev Med Chil 1996;124:1149.
12. Akova M, Akalin HE, Uzun O, Gur D. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis 1991;10:598-9.
13. Lo HJ, Ho AH, Ho M. Factors accounting for mis-identification of Candida species. J Microbiol Immunol Infect 2001;34:171-7.
14. National Committee of Clinical Laboratory Standards 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; M27 approved standard Wayne, PA: NCCLS; 1997.
15. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002;2:73-85.
16. Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979;91:539-43.
17. Vanden Bossche H, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi. Trends Microbiol 1994;2:393-400.
18. Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987;9:1006-12.
19. White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14-alpha demethylase in Candida albicans. Antimicrob Agents Chemother 1997;41:1488-94.
20. White TC. Increased mRNA levels of ERG16, CDR, and MDRI correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 1997;41:1482-7.
21. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998;11:382-402.